Skip to content

Insider · CIK 0001927062

Patrick D. Kirwin

director

Files at PMN (ProMIS Neurosciences Inc.). First filing Apr 23, 2026, latest Apr 23, 2026.

In brief

Patrick D. Kirwin files SEC Form 4 as director at PMN (ProMIS Neurosciences Inc.). Since Apr 23, 2026, Patrick D. Kirwin has reported 1 open-market buy worth $45k and 0 open-market sells worth $0, the latest filed on Apr 23, 2026.

A track record needs three past buys with six months of prices behind them; Patrick D. Kirwin has 0, so none is measured yet.

The newest scored trade: bought $45k of PMN on Apr 22, 2026, filed Apr 23, 2026, scored 39 (weak). In the last 12 months: 1 buy worth $45k and 0 sells worth $0.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$45k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

PMN: ProMIS Neurosciences Inc.

PMNOct 9, 2026 · close 9.61

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
39Weak
PMNbuy
ProMIS Neurosciences Inc.
$45k
4,000 shares
+613%+64% from low-60% from high

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Apr 22, 2026PMN
ProMIS Neurosciences Inc.
POpen-market purchase
Common Sharesindirect: By Patrick D. Kirwin Professional Corp
+4,000$11.33$45k4,653Apr 23, 2026
Feb 3, 2026PMN
ProMIS Neurosciences Inc.
AGrant or award
Common Shares
+3,050$12.13$37k5,135Feb 5, 2026
Feb 3, 2026PMN
ProMIS Neurosciences Inc.
AGrant or award
Warrants to purchase Common Sharesderivative
+3,050--3,050Feb 5, 2026
Jun 12, 2025PMN
ProMIS Neurosciences Inc.
AGrant or award
Option (right to buy)derivative
+20,000$0.00$020,000Jun 16, 2025

Questions about Patrick D. Kirwin

Answered from the filings on this page, as of the latest one.

Is Patrick D. Kirwin buying or selling?

In the last 12 months Patrick D. Kirwin reported 1 open-market buy worth $45k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $45k of PMN on Apr 22, 2026. Grants, option exercises and tax withholding are not counted.

How did Patrick D. Kirwin's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrick D. Kirwin has 0.

Where does Patrick D. Kirwin file Form 4?

Patrick D. Kirwin has filed Form 4 at PMN (ProMIS Neurosciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Patrick D. Kirwin: insider trades and track record | InsiderTell